PMA P050047

Device
Juvéderm Ultra XC; Juvéderm Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S086
Product code
LMH
Decision date
2026-11-04
Generic name
Implant, dermal, for aesthetic use
Approval order statement
approval for the use of an additional supplier of High Molecular Weight (HMW) Sodium Hyaluronate (NaHA) as a raw material in the manufacture of Juvéderm formulations.

Current openFDA PMA Record#

Device
Juvéderm Ultra XC; Juvéderm Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S106
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2026-11-04
Decision code
APPR
Date received
2025-09-04
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
approval for the use of an additional supplier of High Molecular Weight (HMW) Sodium Hyaluronate (NaHA) as a raw material in the manufacture of Juvéderm formulations.